Market Place
Sourcing Support
Parexel`s Emissions Targets Validated By Science Based Target Initiative
12 Aug 2024 //
GLOBENEWSWIRE
Ben Dudley Joins MMS As Chief Commercial Officer
17 Jul 2024 //
BUSINESSWIRE
Parexel collaborates with Japanese Foundation for cancer research
17 Jan 2024 //
INDIAN PHARMA POST
Parexel Named œBest Contract Research Organization at 19th Annual Scrip Awards
17 Nov 2023 //
GLOBENEWSWIRE
Parexel™s Amy McKee, M.D. Named to 2023 PharmaVoice 100
20 Sep 2023 //
GLOBENEWSWIRE
Parexel Appoints Gwyn Bebb to Lead Oncology Clinical Development
19 Sep 2023 //
GLOBENEWSWIRE
Parexel & Partex Announce Innovative Alliance Leveraging Artificial Intelligence
15 Aug 2023 //
GLOBENEWSWIRE
Parexel, Partex Partner to Accelerate Drug Discovery and Development
15 Aug 2023 //
CONTRACT PHARMA
Parexel Introduces Expert Series – New Medicines, Novel Insights
28 Feb 2023 //
GLOBENEWSWIRE
Parexel Expands Patient Access to Trials Through New Community Alliance Network
16 Jun 2022 //
GLOBENEWSWIRE
Parexel and n-Lorem Foundation Partner for New Investigational Therapies
23 Feb 2022 //
BUSINESSWIRE
Parexel Extends Strategic Partnership with Medidata for Decentralized Trials
04 Feb 2022 //
BUSINESSWIRE
Parexel’s Peyton Howell and Sofia Baig Named to 2021 PharmaVOICE 100
02 Aug 2021 //
GLOBENEWSWIRE
Parexel Announces Innovative Partnership with Rare Disease Foundation in China
22 Jul 2021 //
GLOBENEWSWIRE
Parexel Announces Innovative Partnership with Rare Disease Foundation in China
22 Jul 2021 //
GLOBENEWSWIRE
Parexel Commended by Frost & Sullivan for Developing Flexible and Agile Delivery
19 Jul 2021 //
PR NEWSWIRE
Parexel International, on $8.5 Billion Acquisition by Goldman Sachs
07 Jul 2021 //
PR NEWSWIRE
Parexel International, on $8.5 Billion Acquisition by Goldman Sachs
07 Jul 2021 //
PR NEWSWIRE
Parexel Expands Asia Capability through Enhanced Clinical Trial Supplies
07 Jul 2021 //
GLOBENEWSWIRE
Parexel will be acquired by EQT Private Equity & Goldman Sachs Asset Management
06 Jul 2021 //
GENENG NEWS
Global Clinical Research Firm Parexel to Be Acquired for $8.5 Billion
06 Jul 2021 //
BIO SPACE
Parexel to be acquired in $8.5B private-equity deal
05 Jul 2021 //
BIOSPECTRUMASIA
EQT Private Equity and Goldman Sachs Asset to acquire Parexel
02 Jul 2021 //
PHARMABIZ
Parexel snapped up, again, as Goldman Sachs, EQT spend $8.5B
02 Jul 2021 //
FIERCEBIOTECH
EQT and Goldman to Buy Parexel
01 Jul 2021 //
WSJ
Parexel and Veeva Systems collaborate to advance clinical trial technology
15 Apr 2021 //
CLINICALTRIALSARENA
Synairgen joins with Parexel Biotech to study COVID-19 drug
24 Nov 2020 //
OUTSOURCING-PHARMA
Parexel’s EPCU Berlin and CTC North partner on clinical trial research
24 Nov 2020 //
CLINICALTRIALSARENA
Tiziana Life Sciences announces collab with Parexel Biotech to conduct ph 1b/2
11 Nov 2020 //
GLOBENEWSWIRE
Parexel Biotech Collaborates with Synairgen on Pivotal Phase III TriaL
19 Oct 2020 //
GLOBENEWSWIRE
After Icon, PPD and Syneos, Pfizer pens updated Parexel deal, a clean sweep
27 Aug 2020 //
FIERCE BIOTECH
Parexel, Pfizer Extend Long-Term Partnership
27 Aug 2020 //
CONTRACTPHARMA
Parexel, tapping new partner Datavant, pens TriNetX data deal
06 Jul 2020 //
FIERCE BIOTECH
Vivera Enters Agreement Clinical Study Agreement With Parexel Biotech
09 Dec 2019 //
PRESS RELEASE
